Enbridge Inc
ENB
Shopify Inc
SHOP
The Toronto-Dominion Bank
TD
4
BCE Inc
BCE
5
GoldMining Inc
GOLD
CA Stock MarketDetailed Quotes
VM Voyageur Pharmaceuticals Ltd
- 0.190
- 0.0000.00%
15min DelayTrading Apr 29 16:00 ET
30.48MMarket Cap-19.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.190Pre Close0.00Turnover0.24552wk High0.00%Turnover Ratio160.43MShares0.04052wk Low-0.01EPS TTM27.89MFloat Cap0.400Historical HighLossP/E (Static)146.77MShs Float0.035Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM63.33P/B1Lot Size--Div YieldTTM
Voyageur Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 69.50%-302.29K | 76.75%81.14K | 86.80%-11.07K | 60.49%-189.29K | 61.39%-183.07K | 42.33%-991.25K | 125.17%45.91K | 92.37%-83.83K | -323.22%-479.13K | -46.31%-474.2K |
| Net income from continuing operations | -21.99%-1.71M | -62.40%-458.51K | -193.05%-357.39K | 9.51%-562.4K | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 71.48%-121.96K | -23.28%-621.49K | -51.08%-373.69K |
| Operating gains losses | 181.97%1.01K | ---5.1K | ---1.24K | --6.11K | --1.25K | -119.92%-1.24K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -28.15%1.57K | -28.21%392 | -28.15%393 | -28.21%392 | -28.02%393 | -76.28%2.19K | -92.23%546 | -24.76%547 | -24.90%546 | -24.90%546 |
| Asset impairment expenditure | -83.66%7.94K | ---- | ---- | ---- | ---- | --48.61K | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | 99.74%467.44K | 554.52%79.95K | 184.22%22.88K | 7.80%239.55K | 367.25%125.07K | 12.90%234.03K | -87.39%12.22K | -124.60%-27.16K | --222.21K | --26.77K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---1 | -74.21%14.48K | --14.48K | ---- | ---- | ---- |
| Change In working capital | 741.56%926.98K | 79.98%456.47K | 299.91%324.29K | 231.33%127.05K | 114.99%19.17K | 145.19%110.15K | 12.17%253.63K | 110.36%81.09K | -124.79%-96.75K | -64.97%-127.82K |
| -Change in receivables | -33.85%-16.13K | -56.94%-14.58K | -159.10%-10.47K | -43.12%-9.16K | 228.36%18.08K | -168.26%-12.05K | -1,108.36%-9.29K | -44.27%17.72K | 26.13%-6.4K | -120.13%-14.08K |
| -Change in inventory | ---56.5K | ---56.5K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Change in prepaid assets | -166.27%-33.88K | -70.47%4.99K | 494.81%45.98K | -4.55%46.33K | -4,816.94%-131.18K | 174.84%51.12K | -60.24%16.9K | 90.13%-11.65K | 5,004.21%48.54K | -142.46%-2.67K |
| -Change in payables and accrued expense | 1,354.05%1.03M | 112.41%522.56K | 284.94%288.78K | 164.71%89.88K | 219.09%132.27K | 136.93%71.08K | 34.21%246.02K | 110.77%75.02K | -134.90%-138.89K | -43.56%-111.07K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 69.50%-302.29K | 76.74%81.14K | 86.80%-11.07K | 60.49%-189.29K | 61.39%-183.07K | 42.33%-991.25K | 125.17%45.91K | 92.37%-83.83K | -323.22%-479.13K | -46.31%-474.2K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K | 10.44%-37.55K | 36.27%-174.72K | 11.66%-33.21K | 15.65%-54.74K | -291.95%-44.85K | 78.51%-41.92K |
| Net other investing changes | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K | 10.44%-37.55K | 38.24%-174.72K | ---33.21K | ---54.74K | -291.95%-44.85K | 78.23%-41.92K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 5.02%-165.96K | -6.37%-35.32K | -0.45%-54.99K | 15.05%-38.1K | 10.44%-37.55K | 36.27%-174.72K | 11.66%-33.21K | 15.65%-54.74K | -291.95%-44.85K | 78.51%-41.92K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -44.41%631.73K | 1,033.71%116.71K | 242.00%55.92K | -138.59%-9.19K | -58.80%468.28K | -6.19%1.14M | 3.88%-12.5K | -98.62%16.35K | -145.79%-3.85K | 3,760.51%1.14M |
| Net common stock issuance | -45.37%655.5K | 1,436.00%167K | -96.76%530 | -46.30%-5.63K | -58.86%493.6K | -3.70%1.2M | -194.74%-12.5K | -98.69%16.35K | ---3.85K | --1.2M |
| Proceeds from stock option exercised by employees | --5.1K | ---50.29K | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | 54.49%-28.88K | --0 | --0 | ---3.56K | 60.09%-25.32K | -7.54%-63.45K | --0 | --0 | --0 | ---63.45K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -44.41%631.73K | 1,033.71%116.71K | 242.00%55.92K | -138.61%-9.19K | -58.80%468.28K | -6.19%1.14M | 3.88%-12.5K | -98.62%16.35K | -145.79%-3.85K | 3,760.51%1.14M |
| Net cash flow | ||||||||||
| Beginning cash position | -93.39%2.09K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K | -93.39%2.09K | -96.12%31.56K | -99.29%1.88K | -48.68%124.1K | 101.67%651.94K | -96.12%31.56K |
| Current changes in cash | 654.63%163.48K | 79,966.01%162.53K | 91.71%-10.13K | 55.18%-236.58K | -60.08%247.67K | 96.23%-29.48K | 100.09%203 | -638.30%-122.22K | -548.18%-527.83K | 226.68%620.37K |
| End cash Position | 7,840.96%165.57K | 7,840.96%165.57K | 61.26%3.04K | -89.39%13.17K | -61.69%249.75K | -93.39%2.09K | -93.39%2.09K | -99.29%1.88K | -48.68%124.1K | 101.67%651.94K |
| Free cash from | 69.50%-302.29K | 76.74%81.14K | 86.80%-11.07K | 60.49%-189.29K | 61.39%-183.07K | 42.33%-991.25K | -15.26%45.91K | 93.71%-83.83K | -323.22%-479.13K | -45.20%-474.2K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.